EnsoData Boosts AI Sleep Tech With $20M Series B Funding, Targets Underdiagnosis Crisis
The company's flagship product, EnsoSleep PPG, is an FDA-cleared software platform that uses AI to monitor and diagnose sleep disorders. Key ...
Read the original at Citeline News & Insights ↗
- Topics
- HealthcareMarkets & Investment
- Mentions
- FDA
- Tracked via
- “that uses AI to”